课题基金 / 基金详情

Molecular pathology of SLC25A46, a degenerate mitochondrial carrier protein causing early onset neurodegenerative disease

Molecular pathology of SLC25A46, a degenerate mitochondrial carrier protein causing early onset neurodegenerative disease
SLC25A46（一种导致早发性神经退行性疾病的简并线粒体载体蛋白）的分子病理学
批准号：
346445
负责人：
Shoubridge Eric A
金额：
$28.68万
依托单位：
Montreal Neurological Institute-Hospital
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-03-01 至 2019-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=346445&lang=en
关键词：
Cell Cycle Regulation Cellular Senescence Lipid Transfer Membrane Biogenesis Mitochondrial Cristae Architecture Mitochondrial Disease Mitochondrial Er Contacts Mitochondrial Metabolite Carrier

项目摘要

项目成果

Shoubridge Eric A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
All cells in the body require a steady source of chemical energy to carry out their normal physiological functions. The majority of this chemical energy, which is packaged as a compound called ATP, is produced by the oxidation of carbohydrate and fat in a
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of the mitochondrial carrier family protein SLC25A46 in mitochondrial dynamics and early onset neurodegenerative diseases
Functional analysis of mitochondrial-endoplasmic reticulum contact sites
The pathogenesis of CHCHD10 in familial ALS
Posttranscriptional regulation of mitochondrial gene expression
海外基金